Beckman Coulter to Sell $525M in Notes to Support R&D, Pay Off Debt | GenomeWeb
NEW YORK (GenomeWeb News) — Beckman Coulter today said it plans to issue $525 million worth of convertible senior notes to help it pay off existing debt and pay for research and development.
 
The company also said it may buy back $100 million of its common stock to help that end.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.